Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
absorbed, ACE, Actinium, adaptive, adulterated, Agriculture, ahead, aim, aimed, alpha, Amerisource, antiviral, ARC, attend, attendant, AWE, beneficiary, biliary, billed, Bone, bribe, buying, Cardinal, catastrophic, category, CCA, ccRCC, Ceiling, chair, chance, chargeback, cholangiocarcinoma, chosen, closure, COBRA, cold, Colorado, conflict, constitutionality, copay, CRADA, cyberwarfare, Danish, Darmstadt, degradation, dental, destroyed, disaster, dispensing, diversification, downstream, endorsement, England, Enzyvant, epidermal, escape, evidentiary, faster, FD, Florida, fluid, frozen, FSS, God, GU, Hampshire, histology, HMR, Horizon, HPV, hypoxia, ice, ICI, immigration, impeded, ineffective, ineligible, infection, inflation, injunction, instability, interaction, IST, Jebediah, jeopardy, journey, justification, kickback, landmark, Ledell, LinkedIn, macroeconomic, malignancy, McKesson, MHRA, nationwide, navigate, NCCN, NiKang, nondiscrimination, nonrevocation, opt, overcharged, path, payer, percentile, phenomenon, philosophy, Polytechnic, pool, PPACA, PREA, preexisting, pro, proliferation, prompt, proper, PSP, qualification, radioisotope, radiotherapy, rata, reactivate, ready, reassign, Recordati, registry, reinforce, resell, resistant, resupply, Retail, RTF, salvaged, Scotland, screening, seasonal, sector, SI, SIP, solid, solution, specialty, stagnant, standing, stratified, supersede, surface, Surgical, survey, talent, terrorist, tract, trajectory, TriCare, true, Twitter, UF, unanimously, unpaid, upcoming, vaccine, Vermont, video, Warhead, wholesale, wholly, Worcester
Removed:
AbbVie, adherence, AG, al, allegedly, altogether, Anderson, appeal, appealed, Arizona, Array, Assistant, attest, auction, Bauman, Bayer, Bernard, Betta, Binghamton, biomarker, BioPharma, Bob, borrowed, brand, bringing, Brooklyn, calculating, cancellable, capitalizable, captioned, Celgene, center, Century, circumvent, clarify, colorectal, Columbia, complaint, confirmation, cooperate, counsel, crizotinib, crossover, CTA, David, deferment, delivered, DePinho, derived, direction, discordance, dismissal, dispute, division, dosed, Downstate, dropout, Ehrlich, electorate, Eli, escrow, Escudier, ESMO, estimable, evaluable, evidenced, experiencing, exploiting, faculty, favoring, fellowship, flow, Foundation, Fred, fulfill, geographic, glesatinib, graduated, Gustave, Hackel, hazard, hearing, hedge, hematology, Houston, Hutchinson, Hutchison, Iceland, imbalance, Incyte, Institut, investigative, irrespective, Iyer, jeopardize, Johnston, Julie, juncture, Keith, keytruda, leaving, lenalidomide, Levine, ligand, Lilly, liquidation, LLP, load, Matthew, mature, MD, mediated, MediPharma, Megace, memorandum, merestinib, Mirati, MMRF, modified, motion, MOU, moved, MPH, multicenter, Myeloma, Needle, overhaul, Park, pazopanib, pembrolizumab, penalty, Pennsylvania, perpetual, played, pomalyst, pomolidimide, pose, prejudice, prepaid, Professor, prolong, purported, purportedly, qualifying, reclassified, reconsideration, referring, reflecting, regime, regorafenib, removed, Renuka, reposition, resolution, resubmission, retrospective, revalued, revlimid, RMS, Ronald, Roswell, Roussy, rulemaking, Sarcopenia, savolitinib, Seattle, serve, session, settled, Slichenmyer, Southern, speculative, stipulation, Stivarga, sunitinib, SUNY, supplied, Sutent, tasked, Taxpayer, technique, telephone, tepotinib, territorial, tied, trended, trillion, Tuan, unspecified, vacate, variability, viral, voted, Votrient, Washington, William, Windham, withholding, Xalkori, Yervoy, York
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 EX-3.1
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.32 EX-10.32
- 10.39 EX-10.39
- 10.47 EX-10.47
- 10.48 EX-10.48
- 21.1 EX-21.1
- 23.1 EX-23.1
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Related press release
Associated AVEO transcripts
AVEO similar filings
Filing view
External links
SUBSIDIARIES OF THE REGISTRANT
Name Jurisdiction of Organization Percentage Ownership
AVEO Pharma Limited United Kingdom 100%
AVEO Securities Corporation Massachusetts 100%
AVEO Pharma (Ireland) Limited Ireland 100%